Greenleaf Trust’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.87M | Sell |
16,494
-242
| -1% | -$71.9K | 0.05% | 104 |
|
|
2025
Q4 | $4.57M | Buy |
16,736
+108
| +0.6% | +$29.3K | 0.04% | 109 |
|
|
2025
Q3 | $4.49M | Sell |
16,628
-121
| -0.7% | -$32.9K | 0.04% | 107 |
|
|
2025
Q2 | $4.62M | Sell |
16,749
-393
| -2% | -$107K | 0.04% | 110 |
|
|
2025
Q1 | $4.55M | Buy |
17,142
+11,780
| +220% | +$2.91M | 0.04% | 112 |
|
|
2024
Q4 | $1.25M | Buy |
5,362
+356
| +7% | +$81.9K | 0.01% | 277 |
|
|
2024
Q3 | $1.1M | Sell |
5,006
-14
| -0.3% | -$2.9K | 0.01% | 313 |
|
|
2024
Q2 | $987K | Sell |
5,020
-261
| -5% | -$53.9K | 0.01% | 299 |
|
|
2024
Q1 | $1.14M | Sell |
5,281
-195
| -4% | -$41K | 0.01% | 279 |
|
|
2023
Q4 | $1.15M | Buy |
5,476
+295
| +6% | +$62.9K | 0.01% | 273 |
|
|
2023
Q3 | $1.04M | Buy |
5,181
+186
| +4% | +$37K | 0.01% | 268 |
|
|
2023
Q2 | $926K | Sell |
4,995
-469
| -9% | -$86.7K | 0.01% | 300 |
|
|
2023
Q1 | $1.05M | Buy |
5,464
+1,058
| +24% | +$191K | 0.01% | 273 |
|
|
2022
Q4 | $741K | Sell |
4,406
-399
| -8% | -$69.3K | 0.01% | 334 |
|
|
2022
Q3 | $851K | Buy |
4,805
+102
| +2% | +$20.2K | 0.01% | 266 |
|
|
2022
Q2 | $963K | Sell |
4,703
-107
| -2% | -$22.7K | 0.01% | 238 |
|
|
2022
Q1 | $1.14M | Buy |
4,810
+675
| +16% | +$159K | 0.01% | 224 |
|
|
2021
Q4 | $945K | Buy |
4,135
+636
| +18% | +$140K | 0.01% | 260 |
|
|
2021
Q3 | $677K | Sell |
3,499
-25
| -0.7% | -$5.07K | 0.01% | 313 |
|
|
2021
Q2 | $749K | Sell |
3,524
-294
| -8% | -$62.1K | 0.01% | 293 |
|
|
2021
Q1 | $780K | Buy |
3,818
+1,028
| +37% | +$202K | 0.01% | 258 |
|
|
2020
Q4 | $508K | Sell |
2,790
-52
| -2% | -$8.84K | 0.01% | 335 |
|
|
2020
Q3 | $475K | Sell |
2,842
-130
| -4% | -$21.9K | 0.01% | 297 |
|
|
2020
Q2 | $483K | Buy |
2,972
+321
| +12% | +$57.5K | 0.01% | 283 |
|
|
2020
Q1 | $458K | Buy |
2,651
+78
| +3% | +$15.5K | 0.01% | 259 |
|
|
2019
Q4 | $516K | Buy |
2,573
+146
| +6% | +$30K | 0.01% | 286 |
|
|
2019
Q3 | $513K | Buy |
2,427
+137
| +6% | +$28.6K | 0.01% | 280 |
|
|
2019
Q2 | $445K | Buy |
2,290
+314
| +16% | +$57.9K | 0.01% | 304 |
|
|
2019
Q1 | $325K | Sell |
1,976
-650
| -25% | -$115K | 0.01% | 367 |
|
|
2018
Q4 | $494K | Buy |
2,626
+604
| +30% | +$112K | 0.01% | 257 |
|
|
2018
Q3 | $344K | Buy |
2,022
+220
| +12% | +$37K | 0.01% | 362 |
|
|
2018
Q2 | $295K | Buy |
+1,802
| New | +$294K | 0.01% | 376 |
|
|
2018
Q1 | – | Sell |
-199
| Closed | -$29K | – | 561 |
|
|
2017
Q4 | $29K | Sell |
199
-29
| -13% | -$4.13K | ﹤0.01% | 537 |
|
|
2017
Q3 | $31K | Buy |
+228
| New | +$28.8K | ﹤0.01% | 496 |
|
Other funds holding CME
VCM
VPM
Greenleaf Trust's CME Position: Q1 2026 in Review
Greenleaf Trust reduced its CME Group (CME) stake by 1.4% in Q1 2026, selling an estimated $71.9K and leaving 16,494 shares worth $4.87M. The position accounts for 0.05% of the portfolio, ranked #104.
Greenleaf Trust first reported a position in CME in Q3 2017 and has held it in 34 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- Greenleaf Trust held 16,494 shares of CME Group worth $4.87M as of Q1 2026.
- Greenleaf Trust sold 242 CME Group shares in Q1 2026, an estimated $71.9K.
- CME Group made up 0.05% of Greenleaf Trust's portfolio in Q1 2026, its #104 holding.
- Greenleaf Trust first reported a position in CME Group in Q3 2017 and has held it in 34 quarters since.
- 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on Greenleaf Trust's 13F filing for Q1 2026, filed 27 Apr 2026.